Open AccessNew chiral melatonin-derivatives as multitarget directed ligands to treat Alzheimer’s disease.
Author(s) -
Sin Nombre
Publication year - 2018
Publication title -
ibj plus
Language(s) - English
Resource type - Journals
ISSN - 2531-0151
DOI - 10.24217/2531-0151.18v1s2.00100
Subject(s) - melatonin , pharmacology , alzheimer's disease , neuroscience , disease , chemistry , medicine , psychology